WANG Jie, HUANG Ling. The Efficacy and Safety Profile of Gefitinib versus Standard Chemotherapy for Non-Small Cell Lung Cancer with Mutated EGFR[J]. Journal of Evidence-Based Medicine, 2011, 11(1): 25-27. DOI: 10.3969/j.issn.1671-5144.2011.01.015
|
Citation:
|
WANG Jie, HUANG Ling. The Efficacy and Safety Profile of Gefitinib versus Standard Chemotherapy for Non-Small Cell Lung Cancer with Mutated EGFR[J]. Journal of Evidence-Based Medicine, 2011, 11(1): 25-27. DOI: 10.3969/j.issn.1671-5144.2011.01.015
|
WANG Jie, HUANG Ling. The Efficacy and Safety Profile of Gefitinib versus Standard Chemotherapy for Non-Small Cell Lung Cancer with Mutated EGFR[J]. Journal of Evidence-Based Medicine, 2011, 11(1): 25-27. DOI: 10.3969/j.issn.1671-5144.2011.01.015
|
Citation:
|
WANG Jie, HUANG Ling. The Efficacy and Safety Profile of Gefitinib versus Standard Chemotherapy for Non-Small Cell Lung Cancer with Mutated EGFR[J]. Journal of Evidence-Based Medicine, 2011, 11(1): 25-27. DOI: 10.3969/j.issn.1671-5144.2011.01.015
|
DownLoad: